CPI-1205 |
CPI-1205 : SAM competitive inhibitor of EZH2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| EZH2 |
|
|
SAM competitive
45 nM up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - EZH1: 52 nM
Potency Assay Off-Target:
CPI-1205 was selective for EZH2 over 30 additional protein and DNA methyltransferases.
Selectivity Assessment Description:
CPI-1205 had limited activity against P450 enzymes as well as 54 transporters, receptors and ion ...
Potency Cellular
In Vitro
EZH2
Mode of Action: SAM competitive
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.6b01315
In Vivo Validations
Mouse
Dose: 1 mg/kg (IV), 100 mg/kg (PO)
Route of delivery:
Intravenous, Oral
Plasma half life:
0.402 h (IV)
Systemic clearance:
2.16 L/h/kg (IV)
Organ of interest (O):
Karpas-422 xenograft
Target engagement assay:
CPI-1205 decreased H3K27me3 levels in tumor tissue.
DOI Reference: 10.1021/acs.jmedchem.6b01315
Chemical Information
| Molecular Formula | C27H33F3N4O3 |
| SMILEs | COc1cc(C)[nH]c(=O)c1CNC(=O)c1c(C)n([C@H](C)C2CCN(CC(F)(F)F)CC2)c2ccccc12 |
| InChI | InChI=1S/C27H33F3N4O3/c1-16-13-23(37-4)21(25(35)32-16)14-31-26(36)24-18(3)34(22-8-6-5-7-20(22)24)17(2)19-9-11-33(12-10-19)15-27(28,29)30/h5-8,13,17,19H,9-12,14-15H2,1-4H3,(H,31,36)(H,32,35)/t17-/m1/s1 |
| Molecular weight | 518.25 Da |
| AlogP | 4.72034 |
| HBond acceptors | 7 |
| HBond donors | 2 |
| Atoms | 70 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.